Silvia Mateo-Lozano

Silvia Mateo-Lozano

UNVERIFIED PROFILE

Are you Silvia Mateo-Lozano?   Register this Author

Register author
Silvia Mateo-Lozano

Silvia Mateo-Lozano

Publications by authors named "Silvia Mateo-Lozano"

Are you Silvia Mateo-Lozano?   Register this Author

26Publications

614Reads

35Profile Views

Parathyroid hormone-like hormone plays a dual role in neuroblastoma depending on PTH1R expression.

Mol Oncol 2019 Sep 19;13(9):1959-1975. Epub 2019 Jul 19.

Developmental Tumor Biology Laboratory, Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/1878-0261.12542DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717746PMC
September 2019

Regulation of Differentiation by Calcium-Sensing Receptor in Normal and Tumoral Developing Nervous System.

Front Physiol 2016 10;7:169. Epub 2016 May 10.

Developmental Tumor Biology Laboratory, Institut de Recerca Pediàtrica - Hospital Sant Joan de DéuBarcelona, Spain; Department of Oncology, Institut de Recerca Pediàtrica - Hospital Sant Joan de DéuBarcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fphys.2016.00169DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861737PMC
May 2016

Cinacalcet inhibits neuroblastoma tumor growth and upregulates cancer-testis antigens.

Oncotarget 2016 Mar;7(13):16112-29

Developmental Tumor Biology Laboratory, Institut de Recerca Pediàtrica - Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.7448DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941301PMC
March 2016

RHOA inactivation enhances Wnt signalling and promotes colorectal cancer.

Nat Commun 2014 Nov 21;5:5458. Epub 2014 Nov 21.

1] Group of Molecular Oncology, CIBBIM-Nanomedicine, Vall d'Hebron University Hospital, Research Institute (VHIR), Universitat Autònoma de Barcelona, Passeig Vall d'Hebron, 119-129, Barcelona 08035, Spain [2] CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), 28029 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms6458DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255233PMC
November 2014

The dual inhibitory effect of thiostrepton on FoxM1 and EWS/FLI1 provides a novel therapeutic option for Ewing's sarcoma.

Int J Oncol 2013 Sep 12;43(3):803-12. Epub 2013 Jul 12.

Department of Radiation Medicine, Molecular Oncology Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo.2013.2016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787886PMC
September 2013

Brush border myosin Ia inactivation in gastric but not endometrial tumors.

Int J Cancer 2013 Apr 20;132(8):1790-9. Epub 2012 Oct 20.

Group of Molecular Oncology, CIBBIM-Nanomedicine, Vall d'Hebron University Hospital Research Institute, Universitat Autònoma de Barcelona, Passeig Vall d'Hebron 119-129, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.27856DOI Listing
April 2013

Targeted therapies in sarcomas: challenging the challenge.

Sarcoma 2012 3;2012:626094. Epub 2012 Jun 3.

Laboratori d'Oncología Molecular, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2012/626094DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372278PMC
August 2012

Brush border myosin Ia has tumor suppressor activity in the intestine.

Proc Natl Acad Sci U S A 2012 Jan 18;109(5):1530-5. Epub 2012 Jan 18.

Group of Molecular Oncology, and Group of Drug Delivery and Targeting, Centro de Investigaciones en Bioquímica y Biología Molecular-Nanomedicine, Vall d'Hebron University Hospital Research Institute, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1108411109DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3277176PMC
January 2012

Auto-stimulatory action of secreted caveolin-1 on the proliferation of Ewing's sarcoma cells.

Int J Oncol 2011 May 3;38(5):1259-65. Epub 2011 Mar 3.

Department of Radiation Medicine, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo.2011.963DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335731PMC
May 2011

Caveolin-1 in sarcomas: friend or foe?

Oncotarget 2011 Apr;2(4):305-12

Sarcoma Research Group, Bellvitge Biomedical Research Institute, L'Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248165PMC
http://dx.doi.org/10.18632/oncotarget.255DOI Listing
April 2011

Caveolin-1 modulates the ability of Ewing's sarcoma to metastasize.

Mol Cancer Res 2010 Nov;8(11):1489-500

Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospital Duran i Reynals-3 Planta Gran via s/n Km. 2, 7, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-10-0060DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3679656PMC
November 2010

Caveolin-1 promotes resistance to chemotherapy-induced apoptosis in Ewing's sarcoma cells by modulating PKCalpha phosphorylation.

Int J Cancer 2010 Jan;126(2):426-36

Institut d'Investigació Biomédica de Bellvitge, Centre d'Oncología Molecular, L'Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.24754DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2794946PMC
January 2010

The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis.

Cancer Res 2009 Sep 8;69(18):7430-8. Epub 2009 Sep 8.

Group of Molecular Oncology, Biochemistry Research Center (CIBBIM-Nanomedicine) and Department of Pathology, Vall d'Hebron Hospital, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-09-0706DOI Listing
September 2009

Pyrazolo[1,5-a]-1,3,5-triazine as a purine bioisostere: access to potent cyclin-dependent kinase inhibitor (R)-roscovitine analogue.

J Med Chem 2009 Feb;52(3):655-63

Institut de Chimie et Biochimie Moleculaires et Supramoleculaires, UMR-CNRS 5246, Laboratoire de Chimie Organique 1, Universite de Lyon, Universite Claude Bernard-Lyon 1, Batiment Curien, 43 Boulevard du 11 Novembre 1918, F-69622 Villeurbanne, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/jm801340zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744883PMC
February 2009

Combined transcriptional and translational targeting of EWS/FLI-1 in Ewing's sarcoma.

Clin Cancer Res 2006 Nov;12(22):6781-90

Laboratory of Experimental Carcinogenesis, Department of Radiation Medicine, V.T. Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia 20057-1482, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-0609DOI Listing
November 2006

Caveolin-1 (CAV1) is a target of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing's sarcoma cells.

Cancer Res 2006 Oct;66(20):9937-47

Laboratory of Experimental Carcinogenesis, Department of Radiation Medicine, Georgetown University Medical Center, Washington, DC 20057, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-06-0927DOI Listing
October 2006

Roscovitine is an effective inducer of apoptosis of Ewing's sarcoma family tumor cells in vitro and in vivo.

Cancer Res 2005 Oct;65(20):9320-7

Laboratory of Experimental Carcinogenesis, Department of Radiation Medicine, Georgetown University Medical Center, Washington, DC 20057-1482, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-05-1276DOI Listing
October 2005

Rapamycin induces apoptosis of JN-DSRCT-1 cells by increasing the Bax : Bcl-xL ratio through concurrent mechanisms dependent and independent of its mTOR inhibitory activity.

Oncogene 2005 May;24(20):3348-57

Laboratory of Experimental Carcinogenesis, Department of Radiation Medicine, Georgetown University Medical Center, Washington, DC, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/1208471
Publisher Site
http://dx.doi.org/10.1038/sj.onc.1208471DOI Listing
May 2005

Rapamycin induces the fusion-type independent downregulation of the EWS/FLI-1 proteins and inhibits Ewing's sarcoma cell proliferation.

Oncogene 2003 Dec;22(58):9282-7

Laboratory of Experimental Carcinogenesis, Department of Radiation Medicine, Georgetown University Medical Center, Washington, DC 20057-1482, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1207081DOI Listing
December 2003

The PCPH oncoprotein antagonizes the proapoptotic role of the mammalian target of rapamycin in the response of normal fibroblasts to ionizing radiation.

Cancer Res 2003 Oct;63(19):6290-8

Laboratory of Experimental Carcinogenesis, Department of Radiation Medicine, Georgetown University Medical Center, 3970 Reservoir Road NW, Washington, DC 20057-1482, USA.

View Article

Download full-text PDF

Source
October 2003